Trending

24/7 MN – (NASDAQ: GLSI) GREENWICH LIFESCIENCES INC. shares are up 10% on light volume in pre-market trading. The company announced they can proceed with phase 3 trials. The stock is $9.37 a share and has more than 1777 trades this summer morning.

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

https://www.businesswire.com/news/home/20220712005542/en/Greenwich-LifeSciences-Announces-Removal-of-Clinical-Hold-Permitting-Phase-III-Clinical-Trial-to-Proceed

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist